Durability of Triple Combination Therapy Versus Stepwise Addition Therapy in Patients With New-Onset T2DM: 3-Year Follow-up of EDICT

OBJECTIVE: To compare the long-term efficacy of initiating therapy with metformin/pioglitazone/exenatide in patients with new-onset type 2 diabetes mellitus (T2DM) versus sequential addition of metformin followed by glipizide and insulin. RESEARCH DESIGN AND METHODS: Drug-naive patients (N = 318) wi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Diabetes Care
Autors principals: Abdul-Ghani, Muhammad, Puckett, Curtiss, Adams, John, Khattab, Ahmad, Baskoy, Gozde, Cersosimo, Eugenio, Triplitt, Curtis, DeFronzo, Ralph A.
Format: Artigo
Idioma:Inglês
Publicat: American Diabetes Association 2021
Matèries:
Emerging Therapies: Drugs and Regimens
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7818318/
https://ncbi.nlm.nih.gov/pubmed/33273042
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc20-0978
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars